Changing the Practice of Medicine
Popular
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Chan Y. Cheah, MBBS
Alessandra Tedeschi, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- NEW EPISODEMinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Aditya Bardia, MD, MPH, FASCO
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
CME/CE
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Aditya Bardia, MD, MPH, FASCO
Jennifer Johnson, MD, PhD
- MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
Clinical Practice
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
- MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
2.00 credits 3 episodesDavid T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Jennifer Johnson, MD, PhD
Programs
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- CME/CE Broadcast Replay
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
1.00 creditRobert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
- MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN